HCG.. Big ATH Breakout (On the way, for 500% to 1000% returns)
Fundamentally::
- Cheapest across the Hospital Industry, with 18x CFO to EBITDA
- Cancer care is in the great tailwind across developed economies, which makes HCG a good play for the long run. As India evolves into a developed country, or India positions itself as a medical treatment outsourcer.
- CEO is capable of envisioning a turnaround in the business
Technically::
- Highest strength across its industry peers
- Fresh breakout of all-time high, may go 5-10x from this level in 5-7 years.
Disclaimer:: Biased.
#Very_high_Skin_in_the_game!
- Cheapest across the Hospital Industry, with 18x CFO to EBITDA
- Cancer care is in the great tailwind across developed economies, which makes HCG a good play for the long run. As India evolves into a developed country, or India positions itself as a medical treatment outsourcer.
- CEO is capable of envisioning a turnaround in the business
Technically::
- Highest strength across its industry peers
- Fresh breakout of all-time high, may go 5-10x from this level in 5-7 years.
Disclaimer:: Biased.
#Very_high_Skin_in_the_game!
פרסומים קשורים
כתב ויתור
המידע והפרסומים אינם אמורים להיות, ואינם מהווים, עצות פיננסיות, השקעות, מסחר או סוגים אחרים של עצות או המלצות שסופקו או מאושרים על ידי TradingView. קרא עוד בתנאים וההגבלות.